Comparison of Chemiluminescence Immunoassay, Enzyme-Linked Immunosorbent Assay and Passive Agglutination for Diagnosis of Mycoplasma Pneumoniae Infection
Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s159227
Full Text
Abstract
Available in
Date
June 1, 2018
Authors
Publisher
Informa UK Limited